A plausible contributor to multiple sclerosis; presentation of antigenic myelin protein epitopes by major histocompatibility complexes S Jakhmola, MF Sk, A Chatterjee, K Jain, P Kar, HC Jha Computers in Biology and Medicine 148, 105856, 2022 | 11 | 2022 |
Cationic and amphiphilic peptide-based hydrogels with dual activities as anticancer and antibacterial agents T Mondal, A Chatterjee, B Hansda, B Mondal, P Sen, A Banerjee Soft Matter 20 (6), 1236-1244, 2024 | 8 | 2024 |
Histidine-containing amphiphilic peptide-based non-cytotoxic hydrogelator with antibacterial activity and sustainable drug release B Hansda, J Majumder, B Mondal, A Chatterjee, S Das, S Kumar, ... Langmuir 39 (21), 7307-7316, 2023 | 8 | 2023 |
Late-Stage Functionalization: Total Synthesis of Beauveamide A and Its Congeners and Their Anticancer Activities S Saha, SS Auddy, A Chatterjee, P Sen, RK Goswami Organic Letters 24 (39), 7113-7117, 2022 | 8 | 2022 |
Coagulation factor VIIa enhances programmed death-ligand 1 expression and its stability in breast cancer cells to promote breast cancer immune evasion S Paul, K Das, A Ghosh, A Chatterjee, A Bhoumick, A Basu, P Sen Journal of Thrombosis and Haemostasis 21 (12), 3522-3538, 2023 | 7 | 2023 |
Thrombin confers chemotherapeutic resistance by promoting transcriptional induction and post-translational stabilization of pro-survival MCL1 in TNBC S Paul, A Chatterjee, K Das, A Ray, A Basu, S Mukhopadhyay, P Sen Journal of Biological Chemistry 301 (1), 2025 | | 2025 |
Deciphering the Comprehensive Structure–Activity Relationship of Sunshinamide for Breast Cancer Therapy through Dual Modulation of Apoptotic and Ferroptotic Pathways via TrxR1 … A Chatterjee, J Mondal, S Paul, H Sharma, RK Goswami, P Sen Journal of Medicinal Chemistry 67 (24), 21952-21974, 2024 | | 2024 |
FVIIa-PAR2 SIGNALING FACILITATES IMMUNE ESCAPE BY REDUCING PHAGOCYTIC POTENTIAL OF MACROPHAGES IN BREAST CANCER. A Ghosh, A Bhoumick, S Paul, A Chatterjee, S Mandal, A Basu, ... Journal of Thrombosis and Haemostasis, 2024 | | 2024 |
Unveiling the anticancer potential of Pestalotioprolide E, an unexplored macrolide: Targeting TRXR1-TRX1-ASK1-P38 signaling cascade in triple-negative breast cancer R Sarkar, D Paul, A Chatterjee, A Bhattacharya, S Pradhan, RK Goswami, ... Toxicology in Vitro 100, 105920, 2024 | | 2024 |
G-Quadruplex Mediated c-myc Specific Downregulation: A Unique Pathway of the Anticancer Action of Immunomodulator Drugs S Sarkar, A Chatterjee, S Paul, A Bisoi, P Sen, PC Singh bioRxiv, 2024.05. 21.595106, 2024 | | 2024 |